PNC Financial Services Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.13K Buy
287
+251
+697% +$4.72K ﹤0.01% 4315
2026
Q1
$629 Sell
36
-350
-91% -$6.95K ﹤0.01% 4862
2025
Q4
$7.58K Sell
386
-81
-17% -$1.68K ﹤0.01% 4062
2025
Q3
$12.9K Sell
467
-186
-28% -$5.72K ﹤0.01% 3832
2025
Q2
$19.9K Sell
653
-345
-35% -$9.8K ﹤0.01% 3572
2025
Q1
$26.9K Buy
998
+771
+340% +$24.4K ﹤0.01% 3405
2024
Q4
$8.15K Buy
227
+45
+25% +$1.68K ﹤0.01% 3870
2024
Q3
$6.9K Sell
182
-136
-43% -$5.59K ﹤0.01% 3934
2024
Q2
$14.4K Sell
318
-165
-34% -$7.59K ﹤0.01% 3624
2024
Q1
$23.4K Sell
483
-61
-11% -$2.99K ﹤0.01% 3369
2023
Q4
$29.2K Sell
544
-337
-38% -$17K ﹤0.01% 3233
2023
Q3
$51.6K Sell
881
-69
-7% -$4.31K ﹤0.01% 2942
2023
Q2
$59.9K Buy
950
+118
+14% +$7.51K ﹤0.01% 2954
2023
Q1
$52.3K Buy
832
+179
+27% +$10.7K ﹤0.01% 2975
2022
Q4
$34.7K Buy
653
+93
+17% +$5.04K ﹤0.01% 3185
2022
Q3
$31K Sell
560
-386
-41% -$25.5K ﹤0.01% 3230
2022
Q2
$69K Buy
946
+63
+7% +$4.69K ﹤0.01% 2804
2022
Q1
$69K Buy
883
+61
+7% +$5.5K ﹤0.01% 2934
2021
Q4
$83K Sell
822
-9
-1% -$898 ﹤0.01% 2821
2021
Q3
$77K Sell
831
-10
-1% -$962 ﹤0.01% 2804
2021
Q2
$85K Sell
841
-226
-21% -$22.7K ﹤0.01% 2754
2021
Q1
$104K Buy
1,067
+30
+3% +$2.73K ﹤0.01% 2555
2020
Q4
$80K Sell
1,037
-95
-8% -$7.35K ﹤0.01% 2628
2020
Q3
$82K Sell
1,132
-184
-14% -$14.8K ﹤0.01% 2434
2020
Q2
$97K Sell
1,316
-157
-11% -$12.3K ﹤0.01% 2348
2020
Q1
$86K Sell
1,473
-340
-19% -$23.6K ﹤0.01% 2303
2019
Q4
$142K Sell
1,813
-88
-5% -$6.48K ﹤0.01% 2287
2019
Q3
$130K Buy
1,901
+627
+49% +$42.1K ﹤0.01% 2395
2019
Q2
$102K Hold
1,274
﹤0.01% 2528
2019
Q1
$108K Sell
1,274
-800
-39% -$83.5K ﹤0.01% 2505
2018
Q4
$245K Sell
2,074
-6
-0.3% -$694 ﹤0.01% 1938
2018
Q3
$251K Hold
2,080
﹤0.01% 2071
2018
Q2
$241K Buy
2,080
+6
+0.3% +$656 ﹤0.01% 2085
2018
Q1
$179K Sell
2,074
-975
-32% -$75.5K ﹤0.01% 2231
2017
Q4
$225K Buy
3,049
+19
+0.6% +$1.27K ﹤0.01% 2128
2017
Q3
$176K Hold
3,030
﹤0.01% 2214
2017
Q2
$195K Sell
3,030
-570
-16% -$35.1K ﹤0.01% 2156
2017
Q1
$208K Hold
3,600
﹤0.01% 2106
2016
Q4
$220K Hold
3,600
﹤0.01% 2062
2016
Q3
$249K Sell
3,600
-74
-2% -$4.88K ﹤0.01% 1963
2016
Q2
$204K Sell
3,674
-3,702
-50% -$223K ﹤0.01% 2074
2016
Q1
$448K Sell
7,376
-698
-9% -$41.1K ﹤0.01% 1615
2015
Q4
$516K Hold
8,074
﹤0.01% 1529
2015
Q3
$540K Buy
8,074
+2
+0% +$141 ﹤0.01% 1524
2015
Q2
$552K Sell
8,072
-1,468
-15% -$93.2K ﹤0.01% 1587
2015
Q1
$530K Hold
9,540
﹤0.01% 1599
2014
Q4
$489K Sell
9,540
-192
-2% -$9.43K ﹤0.01% 1569
2014
Q3
$358K Hold
9,732
﹤0.01% 1659
2014
Q2
$382K Sell
9,732
-400
-4% -$14.8K ﹤0.01% 1568
2014
Q1
$384K Sell
10,132
-360
-3% -$12.6K ﹤0.01% 1547
2013
Q4
$398K Sell
10,492
-370
-3% -$14.2K ﹤0.01% 1514
2013
Q3
$472K Buy
10,862
+770
+8% +$30.9K ﹤0.01% 1388
2013
Q2
$364K Buy
+10,092
New +$307K ﹤0.01% 1455

Other funds holding USNA

PNC Financial Services Group's USNA Position: Q2 2026 in Review

PNC Financial Services Group increased its Usana Health Sciences (USNA) stake by 697% in Q2 2026, buying an estimated $4.72K and bringing the position to 287 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4315.

PNC Financial Services Group first reported a position in USNA in Q2 2013 and has held it in 53 quarters since. The position peaked at $552K in Q2 2015. 46 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • PNC Financial Services Group held 287 shares of Usana Health Sciences worth $6.13K as of Q2 2026.
  • PNC Financial Services Group bought 251 Usana Health Sciences shares in Q2 2026, an estimated $4.72K.
  • Usana Health Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4315 holding.
  • PNC Financial Services Group first reported a position in Usana Health Sciences in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Usana Health Sciences position peaked at $552K in Q2 2015.
  • 46 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.